Beaumont Financial Advisors’s Fidelity MSCI Health Care Index ETF FHLC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.88M Buy
26,740
+2,055
+8% +$152K 0.13% 103
2025
Q4
$1.83M Sell
24,685
-228
-0.9% -$16.4K 0.12% 104
2025
Q3
$1.67M Buy
+24,913
New +$1.61M 0.11% 113
2025
Q2
Sell
-27,462
Closed -$1.88M 384
2025
Q1
$1.88M Buy
27,462
+24,162
+732% +$1.66M 0.15% 96
2024
Q4
$216K Sell
3,300
-19,177
-85% -$1.33M 0.02% 345
2024
Q3
$1.64M Buy
22,477
+1,074
+5% +$76.9K 0.13% 103
2024
Q2
$1.47M Sell
21,403
-209
-1% -$14.1K 0.12% 115
2024
Q1
$1.51M Sell
21,612
-3,537
-14% -$240K 0.12% 105
2023
Q4
$1.63M Buy
25,149
+20,992
+505% +$1.28M 0.15% 95
2023
Q3
$252K Sell
4,157
-170
-4% -$10.7K 0.03% 274
2023
Q2
$273K Hold
4,327
0.03% 279
2023
Q1
$266K Sell
4,327
-35,186
-89% -$2.18M 0.03% 266
2022
Q4
$2.53M Buy
39,513
+34,686
+719% +$2.17M 0.25% 51
2022
Q3
$278K Hold
4,827
0.03% 252
2022
Q2
$293K Sell
4,827
-187,808
-97% -$11.7M 0.03% 248
2022
Q1
$12.6M Buy
192,635
+156,353
+431% +$9.95M 0.96% 29
2021
Q4
$2.49M Sell
36,282
-2,463
-6% -$162K 0.18% 83
2021
Q3
$2.47M Buy
38,745
+1,354
+4% +$89.5K 0.19% 82
2021
Q2
$2.38M Sell
37,391
-83,543
-69% -$5.15M 0.18% 84
2021
Q1
$7.13M Sell
120,934
-28,697
-19% -$1.7M 0.6% 53
2020
Q4
$8.64M Sell
149,631
-21,076
-12% -$1.16M 0.77% 38
2020
Q3
$8.98M Sell
170,707
-67,438
-28% -$3.53M 0.86% 33
2020
Q2
$11.9M Buy
238,145
+226,849
+2,008% +$11M 1.24% 23
2020
Q1
$486K Sell
11,296
-58,877
-84% -$2.79M 0.06% 144
2019
Q4
$3.49M Sell
70,173
-20,425
-23% -$948K 0.34% 67
2019
Q3
$3.93M Sell
90,598
-416
-0.5% -$18.4K 0.39% 63
2019
Q2
$4.1M Sell
91,014
-364,100
-80% -$15.9M 0.42% 59
2019
Q1
$20.3M Buy
455,114
+420,217
+1,204% +$18.3M 2.17% 11
2018
Q4
$1.44M Sell
34,897
-497,678
-93% -$21.9M 0.24% 67
2018
Q3
$24.9M Sell
532,575
-352,403
-40% -$15.7M 2.48% 8
2018
Q2
$36.5M Sell
884,978
-34,551
-4% -$1.41M 3.87% 7
2018
Q1
$36.6M Buy
919,529
+403,329
+78% +$16.7M 4.08% 4
2017
Q4
$20.6M Sell
516,200
-8,176
-2% -$326K 2.42% 11
2017
Q3
$20.7M Buy
524,376
+17,223
+3% +$667K 2.59% 10
2017
Q2
$19.4M Buy
507,153
+45,206
+10% +$1.66M 2.52% 10
2017
Q1
$16.5M Buy
+461,947
New +$16.2M 2.26% 12
2016
Q4
Sell
-283,321
Closed -$9.76M 155
2016
Q3
$9.76M Sell
283,321
-112,510
-28% -$3.93M 1.54% 20
2016
Q2
$13.4M Buy
+395,831
New +$13.2M 2.2% 10
2016
Q1
Sell
-578,919
Closed -$20M 137
2015
Q4
$20M Buy
578,919
+156,030
+37% +$5.27M 3.3% 5
2015
Q3
$14.9M Hold
422,889
2.16% 6
2015
Q2
$14.9M Sell
422,889
-533,129
-56% -$19.2M 2.16% 6
2015
Q1
$33.7M Sell
956,018
-3,042
-0.3% -$105K 1.17% 24
2014
Q4
$31.6M Sell
959,060
-64,205
-6% -$2.05M 1.52% 20
2014
Q3
$31.2M Buy
1,023,265
+96,877
+10% +$2.9M 2.04% 11
2014
Q2
$27M Buy
+926,388
New +$25.9M 1.91% 7

Other funds holding FHLC

Beaumont Financial Advisors's FHLC Position: Q1 2026 in Review

Beaumont Financial Advisors increased its Fidelity MSCI Health Care Index ETF (FHLC) stake by 8.3% in Q1 2026, buying an estimated $152K and bringing the position to 26,740 shares worth $1.88M. The position accounts for 0.13% of the portfolio, ranked #103.

Beaumont Financial Advisors first reported a position in FHLC in Q2 2014 and has held it in 45 quarters since. The position peaked at $36.6M in Q1 2018. 359 funds tracked by Wall St. Rank hold FHLC as of Q1 2026.

  • Beaumont Financial Advisors held 26,740 shares of Fidelity MSCI Health Care Index ETF worth $1.88M as of Q1 2026.
  • Beaumont Financial Advisors bought 2,055 Fidelity MSCI Health Care Index ETF shares in Q1 2026, an estimated $152K.
  • Fidelity MSCI Health Care Index ETF made up 0.13% of Beaumont Financial Advisors's portfolio in Q1 2026, its #103 holding.
  • Beaumont Financial Advisors first reported a position in Fidelity MSCI Health Care Index ETF in Q2 2014 and has held it in 45 quarters since.
  • Beaumont Financial Advisors's Fidelity MSCI Health Care Index ETF position peaked at $36.6M in Q1 2018.
  • 359 funds tracked by Wall St. Rank held Fidelity MSCI Health Care Index ETF as of Q1 2026.

Based on Beaumont Financial Advisors's 13F filing for Q1 2026, filed 5 May 2026.